Placebo for bms-986435-01 clinical trials

A Phase 2A, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986435/MYK-224 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)

This study is looking into a new medication called BMS-986435/MYK-224 for people with a type of heart failure called HFpEF. It's in the early stages and aims to check if the medicine is safe and how the body handles it, compared to a dummy medicine.